Risk assessment of endocrine active chemicals: Identifying chemicals of regulatory concern
Authors:
- Ivana FegertIFIvana Fegert
- Melanie GrossMGMelanie Gross
- Dick LewisDLDick Lewis
- Lennart WeltjeLWLennart Weltje
- Arnd WeyersAWArnd Weyers
- James R. WheelerJWJames R. Wheeler
- Malyka Galay-BurgosMGMalyka Galay-Burgos
Open Access
- 1 October 2012
- journal article
- research article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 64 (1) , 143-154
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Corrigendum to “Science based guidance for the assessment of endocrine disrupting properties of chemicals” [Regul. Toxicol. Pharmacol. 59 (2011) 37–46]Regulatory Toxicology and Pharmacology, 2011
- Evaluation of EPA’s Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening resultsRegulatory Toxicology and Pharmacology, 2011
- Science based guidance for the assessment of endocrine disrupting properties of chemicalsRegulatory Toxicology and Pharmacology, 2011
- Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessmentEnvironmental Toxicology and Chemistry, 2009
- IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for HumansCritical Reviews in Toxicology, 2008
- IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for HumansCritical Reviews in Toxicology, 2006
- A Critical Review of the Scientific Literature on Potential Endocrine-Mediated Effects in Fish and WildlifeEcotoxicology and Environmental Safety, 2001
- Neoplastic Lesions of Questionable Significance to HumansToxicologic Pathology, 1994
- Ranking Possible Carcinogenic HazardsScience, 1987
- Combined two‐generation reproduction‐teratogenesis study of zearalenone in the ratJournal of Applied Toxicology, 1982